4min chapter

Investing Experts cover image

Finding winners in biotech, probably the riskiest sector

Investing Experts

CHAPTER

Intro

This chapter explores the investment journey with Tarsus Pharmaceuticals, particularly its lead drug Xdemvi for treating demodex blepharitis. The discussion includes initial skepticism, financial performance, and strategies for navigating risks in biotechnology investments.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode